GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors (Participants) as per details attached herewith. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith the copies of Newspaper advertisement of extract of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 published today i.e. May 31, 2023 in Business Standard (All Edition in English language) and Mumbai Lakshwadeep (Mumbai Edition in Marathi language). GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on May 30, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_30052023.mp3 Written transcript of the same will be submitted in due course. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a press release being issued by the Company on the captioned subject, the contents of which is self-explanatory. The same is submitted for public dissemination and for your record. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform you that the Company has cleared the physical audit of The Brazilian Health Regulatory Agency (ANVISA) successfully without any observation. The Company has received Good Manufacturing Practices Certificate from ANVISA for its manufacturing unit situated at Unit - 2, Survey No. 171, N. H. No. - 8, Near Grid, Kabilpore, Navsari - 396 424, Gujarat for its manufacturing line 'Steriles: Lyophilized Powders'. This will enable the Company to expand its business in the territory of Brazil. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023 GUFIC BIOSCIENCES LTD. - 509079 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions of the Company in the prescribed format for the half year ended March 31, 2023. GUFIC BIOSCIENCES LTD. - 509079 - Corporate Action-Board approves Dividend
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Monday, May 29, 2023, inter alia, recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year ended March 31, 2023, subject to the approval of the Shareholders at the ensuing Annual General Meeting GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Meeting Held On Monday, May 29, 2023
In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Monday, May 29, 2023, inter alia, considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023 along with the Auditors Report. 2. Recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year ended March 31, 2023, subject to the approval of the Shareholders at the ensuing Annual General Meeting. GUFIC BIOSCIENCES LTD. - 509079 - Results - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2023
In compliance with the Regulation 30 and 33 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the company at its meeting held today i.e., Monday, May 29, 2023 inter alia considered and approved the Audited Financial Results of the company for the quarter and year ended March 31, 2023 along with the Auditors Report.